EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Advancing AAV manufacturing through platform design and process understanding

Pranav Joshi

Cell and Gene Therapy Insights · 31.03.2026 · 12 (2) · 231–239

DOI: 10.18609/cgti.2026.031 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell and Gene Therapy Insights, online erschienen am 31.03.2026. Verfasst von Pranav Joshi. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

“Real‑time visibility into manufacturing would enable faster optimization, improved robustness, and more responsive control strategies, ultimately helping unlock the full potential of advanced AAV production platforms.” Ashling Cannon, Editor, Cell & Gene Therapy Insights , speaks with Pranav Joshi, Associate Director, Upstream CMC Sciences, GEMMA Biotherapeutics, USA, about the evolving mechanics of AAV upstream manufacturing, the continued role of transient systems, and how process biology, platform strategy and analytical technologies may shape the next generation of viral vector production.

Zitieren

APA

Joshi, P. (2026). Advancing AAV manufacturing through platform design and process understanding. Cell and Gene Therapy Insights, 12(2), 231–239. https://doi.org/10.18609/cgti.2026.031

Vancouver

Joshi P. Advancing AAV manufacturing through platform design and process understanding. Cell and Gene Therapy Insights. 2026;12(2):231–239. doi:10.18609/cgti.2026.031

BibTeX
@article{Joshi2026,
  author = {Joshi, Pranav},
  title = {Advancing AAV manufacturing through platform design and process understanding},
  journal = {Cell and Gene Therapy Insights},
  year = {2026},
  volume = {12},
  number = {2},
  pages = {231–239},
  doi = {10.18609/cgti.2026.031}
}
Kostenlos starten →